Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Kayexalate in Lactulose

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2021 - Volume 25, Number 6
View All Articles in Issue

Page(s):  501

Kayexalate in Lactulose Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Kayexalate in Lactulose. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: kayexalate, lactulose, oral suspension, formulation, hyperkalemia, potassium, osmotic stool softener

Related Categories: FORMULATIONS, GASTROENTEROLOGY, CARDIOLOGY, DOSAGE FORMS/DRUG CARRIERS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Kayexalate in Lactulose
Allen Loyd V Jr
Nov/Dec 2021
Pg. 501

Women's Oral Health: Is There a Hormonal Link?
Preckshot John
Jan/Feb 2004
Pg. 10-14

Potassium Chloride 2-mEq/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 67

Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions
Quay Irene
, Tan Edward
Jul/Aug 2001
Pg. 323-324

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

Nitazoxanide 10-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2023
Pg. 420

A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution
Tannous Elias
, Tal Yana, Amarny Kamal
Sep/Oct 2016
Pg. 438-439

Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Kabiche Djamila
, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
Mar/Apr 2017
Pg. 160-163

Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
Jan/Feb 2001
Pg. 9-12

Potassium Iodide 130-mg Capsules and Potassium Iodide 16-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2003
Pg. 61

Suspension Solution, Sugar Free
Allen Loyd V Jr
Jan/Feb 2023
Pg. 58-59

Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2023
Pg. 326

Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 248

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students
Benischek Rita
Mar/Apr 2017
Pg. 105-108

Sorafenib 20-mg/mL in Oil Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 420

Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 321

Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 415

Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 416

Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 505

Return to Top